Maiko Hayashida

A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.

Shinsuke Suzuki, S. Okada, M. Yoshimitsu, 2015, Experimental hematology.

Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area

K. Ishitsuka, M. Yoshimitsu, N. Arima, 2019, International Journal of Hematology.

Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab

K. Ishitsuka, M. Yoshimitsu, Daisuke Nakamura, 2022, Leukemia & lymphoma.

Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema

K. Hayashida, T. Yokooji, Maiko Hayashida, 2022, International journal of molecular sciences.

Genomic and phylogenetic characterization of Elizabethkingia anophelis strains: The first two cases of life-threatening infection in Japan.

Tetsuya Hayashi, Yasuhiro Gotoh, K. Ishitsuka, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

RLTPR Q575E: A novel recurrent gain‐of‐function mutation in patients with adult T‐cell leukemia/lymphoma

Yuetsu Tanaka, K. Ishitsuka, M. Yoshimitsu, 2020, European journal of haematology.

A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.

Shinsuke Suzuki, M. Yoshimitsu, N. Arima, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T‐cell leukaemia‐lymphoma

S. Hanada, Y. Takatsuka, S. Owatari, 2018, British journal of haematology.

Type D lymphomatoid papulosis associated with chemotherapy/chemoradiotherapy‐induced severe chronic lymphocytopenia

T. Kanekura, K. Ishitsuka, K. Fujii, 2019, Journal of dermatology (Print).

Anagrelide with low‐dose aspirin promptly epithelized ulceronecrotic lesion secondary to essential thrombocythemia

T. Kanekura, Y. Higashi, K. Fujii, 2020, The Journal of dermatology.

Identification of putative noncanonical driver mutations in patients with essential thrombocythemia

Shinsuke Suzuki, S. Hanada, S. Owatari, 2023, European journal of haematology.